Predictive factors for the efficacy of the second taxane treatment in patients with advanced cancer
Hisao Imai(Osaka Dental University), Chikashi Ishioka(Tohoku University), Sho Umegaki(Tohoku University), Yasushi Sato(Tokushima University), Keigo Komine(Tohoku University), Ken Saijo(Tohoku University), Yoshifumi Kawamura(Tohoku University), Shin Takahashi(Institute of Aging), Yukinori Okada, Hidekazu Shirota(Tohoku University), Kota Ouchi(Tohoku University), Sakura Hiraide(Tohoku University Hospital), Masato Takahashi(National Hospital Organization Hokkaido Medical Center)
DOAJ (DOAJ: Directory of Open Access Journals)
September 1, 2018
Cited by 0
Related Papers
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
|Circulation|2017|3.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Prevention of Infective Endocarditis
|Circulation|2007|2.8k
A Single Intravenous Infusion of Gamma Globulin as Compared with Four Infusions in the Treatment of Acute Kawasaki Syndrome
|New England Journal of Medicine|1991|1.2k
Diagnosis and therapy of Kawasaki disease in children.
|Circulation|1993|529